Success Stories: EB1A Approval for a Medical Officer and Assistant Professor in the Field of Gastroenterology in 165 days
On October 1st, 2013, we received another EB1A (Alien of Extraordinary Ability) Approval for a Medical Officer and Assistant Professor in the Field of Gastroenterology (Approval Notice).
General Field: Gastroenterology
Position at the Time of Case Filing: Medical Officer and Assistant Professor
Country of Origin: India
Service Center: Nebraska Service Center
State of Residence at the Time of Filing: Missouri
Approval Notice Date: October 1, 2013
Processing Time: 165 days
Case Summary:
Another remarkable client with whom North America Immigration Law Group – WeGreened.comhad the pleasure of working with was a Medical Officer and Assistant Professor from India whose studies have strongly influenced the field of gastroenterology. In his current endeavor, our client is carrying out the only randomized and controlled trial studying the effects of diet and exercise on patients suffering from nonalcoholic steatohepatitis. This work and our client’s other research is very influential for many different types of patient treatment and care, and contributes greatly to improving patient diagnosis, treatment, and overall quality of life. We at North America Immigration Law Group – WeGreened.com demonstrated that our client qualified for classification as an Alien of Extraordinary Ability, that through his research he had risen to the top of his field, and that his continued research would profoundly benefit the U.S.A. We established that this client’s many publications had appeared in notable journals with large impact factors and had been cited over 200 times at the time of filing. His work is primarily focused on performing meta-analyses of contradictory and disorderly data related to a number of important areas of health care, such as the efficacy of stent placement for post-ERCP pancreatitis, prophylactic antibiotic usage for laparoscopic cholecystectomies, and the use of endoscopic ultrasound to diagnose rectal cancer. An independent recommender discussed our client’s achievements saying, “Although I have not worked directly with [Client], I regard him and his research very highly. He has developed innovative new studies and has carried out very helpful meta-analyses in regards to previously confusing preventive and treatment options of gastrointestinal diseases. His previous and current accomplishments in his field bode well for the future of his research pursuits.” By providing extensive documentation and various testimonials we successfully proved our client’s research to be of extraordinary quality. His EB1A application was approved 165 days after its filing.